← 產業報告目錄
Advance Directives Market Size, Share & Trends Analysis Report By Type (Software, Services), By Demographics (Elderly Population, Middle Aged, Young Adults), By End User (B2B Consumers (Healthcare Providers, Payers), B2C Consumers (Patients, Caregivers), Other End-Users), By Region, And By Segment Forecasts, 2025-2034
出版商 InsightAce Analytic產業別 Chemicals & Materials出版日期 2026-01-24頁數 179報告編號 INSIGHTACE-52241671ce
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
With a 2024 valuation of USD 143.5 Bn, the global Advance Directives Market is projected to accelerate to USD 824.3 Bn by 2034, demonstrating a CAGR of 19.2% during the 2025–2034 forecast window.
The Advance Directives sector involves key industry insights & findings from the report:
The escalating investments in the healthcare, and growing chronic disease cases drive the market growth. This domain has witnessed meaningful transformation owing to technological breakthroughs and shifting materials and technology dynamics.
Growth is underpinned by a convergence of factors: rising awareness among end users, continuous product innovation, and the escalating emphasis on efficiency and sustainability within the materials and technology sector.
Segmental analysis reveals differentiated growth across product categories, applications, and geographical regions, with certain niches demonstrating above-average expansion potential.
From a regional perspective, mature markets in North America and Europe continue to hold meaningful shares, while the Asia-Pacific region is gaining momentum through accelerated economic development and escalating investment in the sector.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
The research provides an in-depth evaluation of market forces, competitive positioning, segmental dynamics, and regional trends, equipping stakeholders with actionable intelligence for the forecast period.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Advance Directives Market Snapshot
Chapter 4. Global Advance Directives Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Component Estimates & Trend Analysis
5.1. By Component, & Market Share, 2024 & 2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Component:
5.2.1. Software
5.2.2. Services
Chapter 6. Market Segmentation 2: By Demographics Estimates & Trend Analysis
6.1. By Demographics & Market Share, 2024 & 2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Demographics:
6.2.1. By Elderly Population (> 65 years)
6.2.2. By Middle Aged (40-64 yrs)
6.2.3. By Young Adults (18-39 yrs)
Chapter 7. Market Segmentation 3: By End User Estimates & Trend Analysis
7.1. By End User & Market Share, 2024 & 2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By End User:
7.2.1. B2B
7.2.2. Payers
7.2.3. Providers
7.2.4. B2C
7.2.5. Patients
7.2.6. Caregivers
Chapter 8. Advance Directives Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Advance Directives Market revenue (US$ Million) estimates and forecasts By Component, 2021-2034
8.1.2. North America Advance Directives Market revenue (US$ Million) estimates and forecasts By Demographics, 2021-2034
8.1.3. North America Advance Directives Market revenue (US$ Million) estimates and forecasts By End User, 2021-2034
8.1.4. North America Advance Directives Market revenue (US$ Million) estimates and forecasts by country, 2021-2034
8.2. Europe
8.2.1. Europe Advance Directives Market revenue (US$ Million) By Component, 2021-2034
8.2.2. Europe Advance Directives Market revenue (US$ Million) By Demographics, 2021-2034
8.2.3. Europe Advance Directives Market revenue (US$ Million) By End User, 2021-2034
8.2.4. Europe Advance Directives Market revenue (US$ Million) by country, 2021-2034
8.3. Asia Pacific
8.3.1. Asia Pacific Advance Directives Market revenue (US$ Million) By Component, 2021-2034
8.3.2. Asia Pacific Advance Directives Market revenue (US$ Million) By Demographics, 2021-2034
8.3.3. Asia Pacific Advance Directives Market revenue (US$ Million) By End User, 2021-2034
8.3.4. Asia Pacific Advance Directives Market revenue (US$ Million) by country, 2021-2034
8.4. Latin America
8.4.1. Latin America Advance Directives Market revenue (US$ Million) By Component, (US$ Million) 2021-2034
8.4.2. Latin America Advance Directives Market revenue (US$ Million) By Demographics, (US$ Million) 2021-2034
8.4.3. Latin America Advance Directives Market revenue (US$ Million) By End User, (US$ Million) 2021-2034
8.4.4. Latin America Advance Directives Market revenue (US$ Million) by country, 2021-2034
8.5. Middle East & Africa
8.5.1. Middle East & Africa Advance Directives Market revenue (US$ Million) By Component, (US$ Million) 2021-2034
8.5.2. Middle East & Africa Advance Directives Market revenue (US$ Million) By Demographics, (US$ Million) 2021-2034
8.5.3. Middle East & Africa Advance Directives Market revenue (US$ Million) By End User, (US$ Million) 2021-2034
8.5.4. Middle East & Africa Advance Directives Market revenue (US$ Million) by country, 2021-2034
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. ADvault, Inc.(US)
9.2.2. VyncaCare (US)
9.2.3. WiserCare Inc.(US)
9.2.4. Sharp HealthCare(US)
9.2.5. ACP Decisions (a DBA of Nous Foundation, Inc.) (US)
9.2.6. Iris Healthcare(Aledade, Inc.) (US)
9.2.7. Bronson Health Care Group, Inc. (US)
9.2.8. Koda Health(US)
9.2.9. ThroughCare, Inc.(US)
9.2.10. Vital Decisions LLC (US)
9.2.11. Affirm Health Inc. (US)
9.2.12. MIDEO(US)
9.2.13. New Century Health (US)
9.2.14. Thanacare(US)
9.2.15. Island Health(Canada)
9.2.16. Honor My Decisions LLC (US)
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們